Package 70436-058-05

{"route": ["ORAL"], "spl_id": "1b0de43f-05c2-aed6-e063-6394a90ac5df", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993503", "993518", "993536"], "spl_set_id": ["7c4313fa-bb29-dd50-e053-2991aa0a3005"], "manufacturer_name": ["Slate Run Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-058-01)", "package_ndc": "70436-058-01", "marketing_start_date": "20201102"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-058-02)", "package_ndc": "70436-058-02", "marketing_start_date": "20201102"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-058-05)", "package_ndc": "70436-058-05", "marketing_start_date": "20201102"}], "brand_name": "Bupropion Hydrochloride SR", "product_id": "70436-058_1b0de43f-05c2-aed6-e063-6394a90ac5df", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "70436-058", "generic_name": "bupropion hydrochloride", "labeler_name": "Slate Run Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA211347", "marketing_category": "ANDA", "marketing_start_date": "20201102", "listing_expiration_date": "20261231"}